source
- Takeda advances gene therapy, UK cancer biotech raises $83M, and new blood test may guide Wegovy useA Cleveland‑based biotech announced that a previously halted gene therapy program has been revived, offering a potential new option for patients as the company pursues additional studies. Takeda r…
- Swiss pharma manufacturing remains steady despite tariff threats, impact may take yearsSwiss biotech day event highlighted that pharma manufacturing in Switzerland shows no immediate disruption from geopolitical tensions or potential tariffs. Industry representatives said that while…